Endpoints used in phase III randomized controlled trials of treatment options for COVID-19

Ordinal Scale endpoints 21 (43%) Survival without needs of ventilator utilization 4 (8%) Overall or All-Cause Mortality 3 (6%) Viral Clearance 3 (6%) Clinical stability/remission endpoints 2 (4%) Lung injury score 2 (4%) No. of deaths/need for intubation 2 (4%) Clear Chest CT/Negative PCR 2 (4%) Change in PaO2/FiO2 1 (2%) Rate of comprehensive adverse outcome 1 (2%) % ICU transfers 1 (2%) % Return to Room Air 1 (2%) Hours to recovery 1 (2%) Number of deceased participants or with persistent organ dysfunction 1 (2%)